2 酪氨酸激酶受体（tyrosine kinase receptors） VEGFR2 属酪氨酸激酶受体，在血流到达后1 ～ 2 min 快速磷酸化与受 体蛋白结合，因此具生物化学和生物机械双重受体作用 ［10］ ...
基于12个网页-相关网页
The family of ErbB tyrosine kinase receptors can transmit signals derived from growth factor of epidermal growth factor family.
属于酪氨酸激酶受体，可以传递表皮生长因子家族的信号。
Sorafenib is an oral multikinase inhibitor with activity against tyrosine kinase receptors that are responsible for blood vessel development and has shown to be active in treating advanced RCC.
索拉非尼是口服的多激酶抑制剂，可以抑制酪氨酸激酶受体，后者促进血管生成并在肾细胞癌中显示出高活性。
I suspect the way this worked when the first transmembrane receptors tyrosine kinase evolved was simply to make activation contingent on phosphorylation of one receptor by the other.
当第一个逐步变化的跨膜受体酪氨酸激酶通过一个受体被另外一个受体磷酸化而轻易实现临时激活时，我怀疑这种作用方式。
应用推荐